Bayesian Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-67,400	Closed	-$1M	–	1087
2023 Q3	$1M	Buy	67,400 +28,500	+73%	+$425K	0.11%	222
2023 Q2	$426K	Buy	+38,900	New	+$426K	0.05%	449
2020 Q4	–	Sell	-22,400	Closed	-$162K	–	701
2020 Q3	$162K	Buy	+22,400	New	+$162K	0.04%	458